Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:Xiuming LIANG - WikiTrademarks Jump to content

Category:Xiuming LIANG

From WikiTrademarks
Revision as of 16:16, 19 July 2024 by Unknown user (talk) (Updating Category:Xiuming_LIANG)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Xiuming LIANG

Executive Summary

Xiuming LIANG is an inventor who has filed 1 patents. Their primary areas of innovation include {Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors} (1 patents), Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers (1 patents), Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers (1 patents), and they have worked with companies such as Evox Therapeutics Limited (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Xiuming LIANG Monthly Patent Applications.png

Technology Areas

File:Xiuming LIANG Top Technology Areas.png

List of Technology Areas

  • A61K47/6901 ({Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors}): 1 patents
  • A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents
  • A61K47/643 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents
  • C12N5/0662 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12P21/02 (having a known sequence of two or more amino acids, e.g. glutathione): 1 patents

Companies

File:Xiuming LIANG Top Companies.png

List of Companies

  • Evox Therapeutics Limited: 1 patents

Collaborators

Subcategories

This category has the following 3 subcategories, out of 3 total.

C

J

X

Cookies help us deliver our services. By using our services, you agree to our use of cookies.